Pacer Advisors
EBS icon

Pacer Advisors’s Emergent Biosolutions EBS Stock Holding History

Pacer Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.45M Buy
+416,191
New +$4.31M 0.01% 726
2025
Q4 		– Sell
-536,655
Closed -$4.73M – 3822
2025
Q3 		$4.73M Sell
536,655
-20,075
-4% -$156K 0.01% 725
2025
Q2 		$3.55M Buy
+556,730
New +$3.19M 0.01% 824
2024
Q3 		– Sell
-75
Closed -$512 – 2601
2024
Q2 		$512 Buy
75
+15
+25% +$65 ﹤0.01% 3741
2024
Q1 		$152 Hold
60
– – ﹤0.01% 3688
2023
Q4 		$144 Sell
60
-15
-20% -$35 ﹤0.01% 3519
2023
Q3 		$255 Hold
75
– – ﹤0.01% 2620
2023
Q2 		$551 Buy
75
+5
+7% +$46 ﹤0.01% 3521
2023
Q1 		$725 Hold
70
– – ﹤0.01% 2171
2022
Q4 		$827 Sell
70
-265,096
-100% -$4.1M ﹤0.01% 3302
2022
Q3 		$5.57M Buy
265,166
+265,054
+236,655% +$7.38M 0.04% 344
2022
Q2 		$3K Hold
112
– – ﹤0.01% 2325
2022
Q1 		$5K Sell
112
-27
-19% -$1.19K ﹤0.01% 2259
2021
Q4 		$6K Sell
139
-5,071
-97% -$229K ﹤0.01% 2178
2021
Q3 		$261K Sell
5,210
-1,595
-23% -$96.6K ﹤0.01% 1292
2021
Q2 		$429K Buy
6,805
+713
+12% +$45.8K 0.01% 1181
2021
Q1 		$566K Sell
6,092
-678
-10% -$69.4K 0.01% 1004
2020
Q4 		$607K Sell
6,770
-5,225
-44% -$480K 0.01% 894
2020
Q3 		$1.24M Buy
11,995
+11,943
+22,967% +$1.29M 0.03% 615
2020
Q2 		$4K Buy
+52
New +$3.88K ﹤0.01% 929
2019
Q1 		– Sell
-11,567
Closed -$686K – 751
2018
Q4 		$686K Buy
11,567
+8,454
+272% +$545K 0.02% 109
2018
Q3 		$205K Buy
+3,113
New +$182K 0.01% 1026
2018
Q2 		– Sell
-1,178
Closed -$62K – 1177
2018
Q1 		$62K Buy
1,178
+503
+75% +$25.1K ﹤0.01% 955
2017
Q4 		$31K Buy
+675
New +$28.4K ﹤0.01% 1062

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Pacer Advisors's EBS Position: Q1 2026 in Review

Pacer Advisors opened a new position in Emergent Biosolutions (EBS) in Q1 2026: 416,191 shares worth $3.45M. The stake represents 0.01% of the portfolio and ranks #726 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in EBS as recently as Q3 2025.

Pacer Advisors first reported a position in EBS in Q4 2017 and has held it in 24 quarters since. The position peaked at $5.57M in Q3 2022. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • Pacer Advisors held 416,191 shares of Emergent Biosolutions worth $3.45M as of Q1 2026.
  • Emergent Biosolutions was a new Pacer Advisors position in Q1 2026.
  • Emergent Biosolutions made up 0.01% of Pacer Advisors's portfolio in Q1 2026, its #726 holding.
  • Pacer Advisors first reported a position in Emergent Biosolutions in Q4 2017 and has held it in 24 quarters since.
  • Pacer Advisors's Emergent Biosolutions position peaked at $5.57M in Q3 2022.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.